Volume 5, Issue 4 pp. 563-573
Article
Full Access

Alexithymia as a predictor of treatment response in post-traumatic stress disorder

Thomas R. Kosten

Thomas R. Kosten

Department of Psychiatry and the West Haven V. A. Medical Center, Yale University School of Medicine and University of Connecticut Health Center

Search for more papers by this author
John H. Krystal

John H. Krystal

Department of Psychiatry and the West Haven V. A. Medical Center, Yale University School of Medicine and University of Connecticut Health Center

Search for more papers by this author
Earl L. Giller Jr

Earl L. Giller Jr

Department of Psychiatry and the West Haven V. A. Medical Center, Yale University School of Medicine and University of Connecticut Health Center

Search for more papers by this author
Julia Frank

Julia Frank

Department of Psychiatry and the West Haven V. A. Medical Center, Yale University School of Medicine and University of Connecticut Health Center

Search for more papers by this author
Elisheva Dan

Elisheva Dan

Department of Psychiatry and the West Haven V. A. Medical Center, Yale University School of Medicine and University of Connecticut Health Center

Search for more papers by this author
First published: October 1992
Citations: 28

Abstract

Fifty-seven veterans with post-traumatic stress disorder (PTSD) completed the Alexithymia Provoked Response Questionnaire (APRQ) upon entering an 8-week randomized trial comparing phenelzine, imipramine, and placebo. Low alexithymia on the APRQ significantly predicted improvement on the avoidance items of the Impact of Events Scale (IES) particularly among patients treated with placebo, but was not associated with changes in the intrusion items of the scale.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.